The nature of an ideal therapeutic human antibody

被引:15
作者
Glassy, MC
Koda, K
机构
关键词
D O I
10.1517/14712598.2.1.1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 9 条
[1]   The immune system - First of two parts [J].
Delves, PJ ;
Roitt, IM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (01) :37-49
[2]   Antibody engineering at the millennium [J].
Gavilondo, JV ;
Larrick, JW .
BIOTECHNIQUES, 2000, 29 (01) :128-+
[3]  
Glassy M. C., 1995, EXPERT OPIN INV DRUG, V4, P225
[4]  
GLASSY MC, 1987, CANCER RES, V47, P5181
[5]  
Glassy MC, 1993, CURR OPIN INVEST DR, V2, P853
[6]  
Glassy MC, 1994, EXPERT OPIN INV DRUG, V3, P1057
[7]  
IOACHIM HL, 1994, LYMPH NODE BIOPSY
[8]  
Koda K, 2001, ANTICANCER RES, V21, P621
[9]  
Kontermann R, 2001, ANTIBODY ENG